Transthyretin Amyloidosis Polyneuropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-08-06
Clinical Trial Update: A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) [Phase 1, Phase 2]
Phase 1/2a open-label study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of YOLT-201 in patients with transthy…